Friday, March 28, 2025
spot_img

Trading by management and close relations of management

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B.

Please see attached the full announcement.

Attachment

  • 2025_07_Trading_By_Management

Powered by SlickText.com

Hot this week

Intercont (Cayman) Limited Announces Pricing of Its Initial Public Offering

HONG KONG, March 27, 2025 (GLOBE NEWSWIRE)...

Yukon Metals Announces Upsize in Private Placement to C$10M

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR...

CORRECTING and REPLACING: Reed’s Reports Fourth Quarter and Full Year 2024 Results

NORWALK, Conn., March 27, 2025 (GLOBE NEWSWIRE)...

VitalHub Reports Fourth Quarter and Annual 2024 Results

Annual Recurring Revenue (ARR)⁽¹⁻²⁾ up 59% YoY to $71.1...

Fortuna files Form 40-F, Annual Report

VANCOUVER, British Columbia, March 27, 2025 (GLOBE...

Topics

Yukon Metals Announces Upsize in Private Placement to C$10M

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR...

VitalHub Reports Fourth Quarter and Annual 2024 Results

Annual Recurring Revenue (ARR)⁽¹⁻²⁾ up 59% YoY to $71.1...

Fortuna files Form 40-F, Annual Report

VANCOUVER, British Columbia, March 27, 2025 (GLOBE...

Acrivon Therapeutics Provides Program Updates and Fourth Quarter and Full Year 2024 Financial Results

Generative Phosphoproteomics AP3 platform designed to enable streamlined, rational...
spot_img

Related Articles

Popular Categories

spot_img